NCT00003649 2023-06-22
Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Eastern Cooperative Oncology Group
Phase 1 Completed
Clinical Trials
17 trialsNCT00003450 2021-02-02
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT03544723 2020-06-09
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
MultiVir, Inc.
Phase 2 Unknown
NCT02842125 2020-06-02
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
MultiVir, Inc.
Phase 1/2 Terminated
NCT00004041 2018-06-27
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT01302821 2017-02-23
C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Withdrawn
NCT00003257 2013-12-04
Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00044993 2013-05-30
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003588 2013-02-08
Gene Therapy in Treating Patients With Ovarian Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003147 2013-02-05
Gene Therapy in Treating Patients With Cancer of The Liver
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00003167 2013-01-23
Gene Therapy in Treating Patients With Advanced Bladder Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00064103 2013-01-23
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00017173 2012-06-14
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 2 Terminated
NCT00410865 2011-12-07
Wild Type p53 Adenovirus for Oral Premalignancies
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00004225 2010-07-07
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00041613 2008-04-01
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
Introgen Therapeutics
Phase 3 Unknown
NCT00286247 2008-04-01
Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
Introgen Therapeutics
Phase 2 Completed